Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-02

FDA Approved: RASAGILINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Rasagiline submitted by Ascend Laboratories, LLC. This action updates the Rasagiline product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RASAGILINE (rasagiline)

Snippet

SUPPL AP for RASAGILINE (RASAGILINE)